
Combined with professionals in clinical gastroenterology, Strong developed Helicobacter pylori in vitro diagnostic devices and related biotech materials. Strong is Taiwan and the world’s first company specializing in producing both paper and gel type Helicobacter pylori in vitro diagnostic test, providing rapid diagnosis of peptic ulcer caused by the H. pylori as the basis of doctor’s prescription.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.